The Cardiac Benefit of Androgen Replacement in Hypogonadal Males with Coronary Artery Disease Following Successful Percutaneous Coronary Intervention (PCI)
ID Number 06-1081Principal Investigator(s)
Mary A McLaughlin
Department(s) or Division(s)
The Zena and Michael A. Wiener Cardiovascular Institute
This is a randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of testosterone supplementation in hypogonadal men with coronary artery disease (narrowing of the arteries giving blood to the heart) following successful percutaneous coronary intervention (PCI),(procedure wherein blockage or narrowed artery is being dilated or stretched to allow better flow of blood in the heart).
Lourdes Campos-Grundvig, RN, MS
Recruiting Patients: Yes